Amendment116th Congress
An amendment numbered 101 printed in Part B of House Report 116-119 to prevent funds from being used to finalize, implement, or enforce the draft guidance issued by the Food and Drug Administration in December of 2017 titled Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry.
- Amendment Number
- 427
- Description
- An amendment numbered 101 printed in Part B of House Report 116-119 to prevent funds from being used to finalize, implement, or enforce the draft guidance issued by the Food and Drug Administration in December of 2017 titled Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry.
- Purpose
- An amendment numbered 101 printed in Part B of House Report 116-119 to prevent funds from being used to finalize, implement, or enforce the draft guidance issued by the Food and Drug Administration in December of 2017 titled Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry.
- Congress
- 116
- Type
- HAMDT
- Latest Action Date
- Jun 20, 2019
- Latest Action Text
- By unanimous consent, the Biggs amendment was withdrawn. (consideration: CR H4944)
- Latest Action Time
- 12:21:03
- Submitted Date
- Jun 20, 2019
- Chamber
- House of Representatives
- Update Date
- Dec 29, 2021